Therapix Biosciences Enters Strategic Collaboration for

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Therapix Biosciences Enters Strategic Collaboration for Development and Commercialization of Oral Anti-CD3 Antibody in China

TEL AVIV, Israel, Dec. 23, 2014 (GLOBE NEWSWIRE) -- Therapix Bio (TASE: TRPX ) (OTCQB:THXBY) today announced that its subsidiary, OrImmune Bio Ltd., has entered into a non-binding memorandum of understanding with Nanjing BioSciKin Co, for a strategic collaboration to develop, manufacture and commercialize the Company's Anti-CD3 antibody in the Chinese market, inclusive of Mainland China, Taiwan, Hong Kong and Macau. The Anti-CD3 antibody is a unique, orally-administered antibody for the treatment of a variety of inflammatory diseases such as Non Alcoholic Steato Hepatitis (fatty liver disease).

Pursuant to the memorandum of understanding, OrImmune and Nanjing BioSciKin are working toward an agreement that would provide Nanjing BioSciKin with an exclusive license to use OrImmune's patents and related intellectual property for the purpose of research, development, manufacture, commercialization and sublicensing in the territory, in consideration for a cash payment of US $300,000. Additionally, Nanjing BioSciKin will be expected to finance the establishment of a GMP-compliant manufacturing line for the antibody. The parties will also enter into a nonexclusive supply agreement for the manufacture of the antibody (under FDA standards) for the purpose of conducting clinical trials, at a price to be determined between the parties. Nanjing BioSciKin shall incur all payments required in connection with and/or deriving from the antibody's commercialization, including payments to the Office of the Chief Scientist, to the extent required. Consummation of the engagements is subject to the satisfaction of several conditions, including the completion of due diligence to the satisfaction of the Chinese corporation, filing of patent applications related to the antibody in China, and the execution of final and binding agreements.

Therapix Chairman Dr. Asher Shmulewitz, commented, "This agreement with Nanjing BioSciKin is an important step forward in the execution of our broader corporate strategy, which focuses on the development of novel synthetic cannabinoids and advancing our position in the emerging market for medical cannabis. With the involvement of Nanjing BioSciKin, we will ensure that the development of the Anti-CD3 antibody will continue, supported by a highly capable and well-funded strategic partner. We look forward to working with Nanjing BioSciKin as they advance the product toward clinical trials in Greater China, while devoting all of our internal resources to the expansion and advancement of our portfolio of cannabinoid-based product candidates."

About Therapix

Therapix, is a biopharmaceutical company focused on locating and investing in promising technologies in the biopharmaceutical field, while concurrently promoting its current technologies. Therapix holds 25% of Lara Pharm, a company engaged in the field of supply of medical and technological solutions for the development of a new generation of medication based on cannabinoids (active compounds in the marijuana plant) to pharma companies. Lara's first product is a unique development consisting of a pharmaceutical substitution for medical marijuana. The Company's portfolio further includes the Anti-CD3 technology, an orally administered antibody for the treatment of various inflammatory diseases such as Non Alcoholic Steato Hepatitis (fatty liver disease).

Noam Yellin - (972) 54 4246720 Iris Lubitz - (972) 54 2528007

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rehab Equipment Growth Meets a Brutal Access Gap

Updated Category News Views 89

Rehabilitation demand is piling up faster than the equipment can reach people. That is the uncomfortable fact sitting beneath Wissen Research's forecast for a global rehabilitation equipment market rising from $19.1 billion in 2026 to $25.8 billion by 2031, a 6.2% annual growth rate. It is a respectable expansion story, not some rocket-ship fairy tale. More important, it...

Continue Reading
Precision Metal Forming Is Industry's Quiet Backbone

Updated Category News Views 88

A fraction of a millimeter can turn a perfectly good industrial part into an expensive headache. That unglamorous reality sits at the center of Michele Caulfield's discussion of precision metal forming for HelloNation, and it deserves more attention than it usually gets. Investors watching manufacturing tend to chase flashy automation headlines, big aerospace orders, or...

Continue Reading
A Parish Memoir That Sends Its Proceeds Back Home

Updated Category News Views 114

Some books arrive with a thunderclap; this one shows up carrying a folding chair, a prayer book, and a memory that refuses to leave. You Give Them Something to Eat, the new memoir from Fr. Michael J Rieder, is built from more than a hundred short chapters rather than one grand, polished life story. That choice fits the material. Parish life is rarely a clean parade of...

Continue Reading
DocLinq Takes Aim at Care Gaps Between Office Visits

Updated Category News Views 149

Healthcare's most expensive loose ends often pile up after the appointment ends. DocLinq, launched from Columbia, Maryland, is taking a run at that awkward stretch between office visits, where records sit in separate systems, chronic-care follow-up gets uneven, and patients are expected to remember far more than any human reasonably can. This is not a story about AI...

Continue Reading
Parents Hand Kids Devices Years Before They Intended

Updated Category News Views 286

A nine-year-old with a smartphone used to raise eyebrows; this survey says it is increasingly the household baseline. All About Cookies, working with parental-control company Bark, surveyed U.S. parents and found that children typically receive personal devices well before their parents believe they should. That mismatch is not some cute little parenting contradiction. It...

Continue Reading
CloudBackend's €6.6M Test: Can Vibe Code Become SaaS?

Updated Category News Views 108

A prototype is cheap theatre; keeping it alive after customers arrive is where the bill lands. CloudBackend has raised €6.6 million to attack that unglamorous, absolutely vital stretch between an AI-made app and an actual software business. The round is led by Carl-Henric Svanberg's family office, while existing backer M2 Asset Management increased its stake. That is a...

Continue Reading
Snowrise Targets the Blind Spots in CPG Sales Data

Updated Category News Views 128

A sales total can look healthy while the floorboards are quietly rotting underneath it. That is the uncomfortable CPG problem Snowrise is aiming at: brands know what moved last quarter, but often cannot identify which stores, channels, communities, or promotions actually created the result. Plenty of management teams still steer by topline revenue, net distribution gains,...

Continue Reading
Hanmi Compressor Tests Vietnam Before Wider Expansion

Updated Category News Views 125

Compressed air is the sort of factory necessity nobody brags about until it fails, and that is precisely why Hanmi Compressor’s Vietnam plan deserves a sober look. The Daegu-based specialist is not arriving with a grand export victory lap. It is still building the front door: a website, a promotional video, and a process for finding Vietnamese manufacturers and...

Continue Reading
Resolve Adds Cahaba in Birmingham Pain-Care Expansion

Updated Category News Views 36

Pain-care consolidation has a peculiar way of looking tidy in a release and messy in the real world. Resolve Pain Solutions announced on November 18, 2026, that it has acquired Cahaba Pain and Spine Care, an established provider serving greater Birmingham, Alabama. On its face, this is a straightforward expansion move: buy a respected local practice, retain its physician...

Continue Reading
Excel Treatment Center Adds ART Trauma Therapy Option

Updated Category News Views 117

Trauma rarely arrives at an addiction program wearing a name tag. Excel Treatment Center in Dover, New Jersey, is responding to that uncomfortable reality by adding Accelerated Resolution Therapy® (ART) to the individual, group, and family therapy already available to its clients. The center says its therapists have completed ART training, and the approach is now part of...

Continue Reading

Top 5 Most Recently Viewed Articles

Current Trends in Short Interest Impacting PayPal Stock

Updated Category News Views 262

Understanding PayPal Holdings Inc and Its Market Position PayPal Holdings Inc (NYSE: PYPL) remains a prominent player in the digital payments space, continuing to see fluctuations in its market sentiment. Recently, the company has noted a significant increase in short interest as a percentage of float, climbing by 11.57%. This rise has brought the total number of shares...

Continue Reading
WillScot Plans Upcoming Earnings Call and Webcast for Q1

Updated Category News Views 152

WillScot Holdings Corporation to Share Q1 Results WillScot Holdings Corporation, a renowned leader in providing innovative temporary flexible space solutions, has announced its schedule for releasing the financial results for the first quarter of 2025. This eagerly anticipated announcement is set to take place on May 1, 2025, after market close, allowing investors and...

Continue Reading
Denarius' Bold Move: Debentures Target Early Exit

Updated Category News Views 53

Treading Against Debentures: Denarius' Maneuver Denarius Metals Corp. doesn't seem keen on playing it safe with convertible debentures tying up its business. Jaw-dropping numbers in news like this make you stop and wonder: Is this strategy brilliance, or just a roll of the dice? Time-Pressured Decisions Denarius Metals, trading as OTCQX: DNRSF, has kicked off a whirlwind...

Continue Reading
Katten Partners Recognized Among Top Experts in Crypto Sector

Updated Category News Views 185

Katten Partners Shine in Crypto Industry Recognition Katten, a well-respected law firm, has gained significant attention for its leadership in the evolving digital asset landscape. Three of its distinguished partners have been recognized by Citywealth, a leading publication in the private wealth sector, for their exceptional contributions to the cryptocurrency domain. The...

Continue Reading
Anticipating Logitech International's Earnings Success

Updated Category News Views 160

Anticipating Logitech International's Earnings Success Logitech International (NASDAQ: LOGI) is gearing up for its next quarterly earnings announcement, and investors are keenly observing potential developments. As the company prepares to report earnings, expectations are high for positive news regarding financial forecasts and results. Analyst Predictions for Earnings...

Continue Reading